These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17822675)

  • 1. Corticotropin-releasing factor family and its receptors: tumor therapeutic targets?
    Wang J; Li S
    Biochem Biophys Res Commun; 2007 Nov; 362(4):785-8. PubMed ID: 17822675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation.
    Inada Y; Ikeda K; Tojo K; Sakamoto M; Takada Y; Tajima N
    Peptides; 2009 Feb; 30(2):365-72. PubMed ID: 19026699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of urocortin via ion mechanisms or CRF receptors?
    Tao J; Li S
    Biochem Biophys Res Commun; 2005 Oct; 336(3):731-6. PubMed ID: 16061206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-expression of neuropeptide urocortin and its receptors in human allergic nasal mucosa.
    Kim TH; Lee SH; Lee HM; Lee SH; Lee SW; Kim WJ; Park SJ; Kim YS; Choe H; Hwang HY; Yoo IO
    Laryngoscope; 2007 Sep; 117(9):1513-8. PubMed ID: 17597629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
    Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
    Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microinjection of urocortin into the rat nucleus tractus solitarii decreases arterial blood pressure.
    Yamazaki T; Waki H; Kohsaka A; Nakamura T; Cui H; Yukawa K; Maeda M
    Auton Neurosci; 2008 Nov; 142(1-2):51-4. PubMed ID: 18804421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides.
    Brar BK; Chen A; Perrin MH; Vale W
    Endocrinology; 2004 Apr; 145(4):1718-29. PubMed ID: 14670995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing factor family and its receptors: pro-inflammatory or anti-inflammatory targets in the periphery?
    Zhu H; Wang J; Li J; Li S
    Inflamm Res; 2011 Aug; 60(8):715-21. PubMed ID: 21476084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The three-dimensional structure of the N-terminal domain of corticotropin-releasing factor receptors: sushi domains and the B1 family of G protein-coupled receptors.
    Perrin MH; Grace CR; Riek R; Vale WW
    Ann N Y Acad Sci; 2006 Jul; 1070():105-19. PubMed ID: 16888152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides.
    Boorse GC; Denver RJ
    Gen Comp Endocrinol; 2006 Mar; 146(1):9-18. PubMed ID: 16413023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing factor receptor type 1, but not type 2, in the ventromedial hypothalamus modulates dopamine release in female rats.
    Muramatsu T; Inoue K; Iwasaki S; Yamauchi T; Hayashi T; Kiriike N
    Pharmacol Biochem Behav; 2006 Oct; 85(2):435-40. PubMed ID: 17109941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathways.
    Tezval H; Jurk S; Atschekzei F; Serth J; Kuczyk MA; Merseburger AS
    Prostate; 2009 Mar; 69(4):443-8. PubMed ID: 19058138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urocortin affects migration of hepatic cancer cell lines via differential regulation of cPLA2 and iPLA2.
    Zhu C; Sun Z; Li C; Guo R; Li L; Jin L; Wan R; Li S
    Cell Signal; 2014 May; 26(5):1125-34. PubMed ID: 24518041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 corticotropin-releasing factor receptors in the ventromedial hypothalamus promote hypoglycemia-induced hormonal counterregulation.
    Cheng H; Zhou L; Zhu W; Wang A; Tang C; Chan O; Sherwin RS; McCrimmon RJ
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E705-12. PubMed ID: 17578887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urocortin and cardiovascular protection.
    Huang Y; Yao XQ; Lau CW; Chan YC; Tsang SY; Chan FL
    Acta Pharmacol Sin; 2004 Mar; 25(3):257-65. PubMed ID: 15000874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of corticotropin-releasing factor receptor 1 selectively inhibits CaV3.2 T-type calcium channels.
    Tao J; Hildebrand ME; Liao P; Liang MC; Tan G; Li S; Snutch TP; Soong TW
    Mol Pharmacol; 2008 Jun; 73(6):1596-609. PubMed ID: 18292205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing factor (CRF) receptor type 2 in the human stomach: protective biological role by inhibition of apoptosis.
    Chatzaki E; Lambropoulou M; Constantinidis TC; Papadopoulos N; Taché Y; Minopoulos G; Grigoriadis DE
    J Cell Physiol; 2006 Dec; 209(3):905-11. PubMed ID: 16972272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urocortins as cardiovascular peptides.
    Takahashi K; Totsune K; Murakami O; Shibahara S
    Peptides; 2004 Oct; 25(10):1723-31. PubMed ID: 15476939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems.
    Sandi C; Cordero MI; Ugolini A; Varea E; Caberlotto L; Large CH
    Eur J Neurosci; 2008 Nov; 28(9):1836-48. PubMed ID: 18973598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization and physiological roles of urocortin.
    Oki Y; Sasano H
    Peptides; 2004 Oct; 25(10):1745-9. PubMed ID: 15476941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.